agilon health names Tim O'Rourke as chief executive officer
Get Alerts AGL Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.6%
Revenue Growth %: +2.1%
Join SI Premium – FREE
agilon health (NYSE: AGL) appointed Tim O'Rourke as chief executive officer and board member, effective May 7, the company announced. O'Rourke succeeds Ronald A. Williams, who will continue as chairman of the board after serving as executive chairman.
The appointment follows a comprehensive search led by the board of directors as the value-based care company enters a new phase after operational and financial transformation efforts.
O'Rourke brings more than 25 years of healthcare leadership experience across payor and provider organizations. He most recently served as president of Help at Home, a national provider of in-home care for Medicare, Medicaid and dual eligible patients with chronic conditions. Previously, O'Rourke held leadership roles at Humana for 17 years, developing expertise in Medicare Advantage and value-based care. He also served as chief executive officer of Ascension Complete, a multi-state provider-integrated Medicare Advantage plan.
"Over the past year, our team has done the hard work of strengthening agilon's foundation, improving our data and technology capabilities, supporting our partners in clinical pathways, reshaping our relationships with key payors," Williams said in a statement.
O'Rourke currently serves as vice-chair of Jefferson's Board of Trustees, which oversees Thomas Jefferson University, Jefferson Health and Jefferson Health Plans. He holds a bachelor's degree in health administration from Northern Illinois University.
agilon health operates a platform that partners with primary care physicians to deliver value-based care to senior patients. The company works with approximately 2,300 primary care physicians across about 30 communities.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
- Gil Issachar steps down as CTO at Firefly Neuroscience
- Morgan Stanley Upgrades Sonova Holding AG (SOON:SW) (SONVY) to Equalweight
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, Hot Mgmt Changes, Management ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share